InterCure Ltd Investor Relations Material
Latest events
Q4 2022
InterCure Ltd
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from InterCure Ltd
Access all reports
InterCure Ltd is a pharmaceutical company focused on the production and distribution of medical cannabis products. Through its subsidiary, Canndoc, the company cultivates and manufactures pharmaceutical-grade cannabis used for medical treatments. InterCure offers a range of cannabis-based products, including oils, flowers, and other formulations designed for therapeutic purposes. The company partners with international healthcare and cannabis companies to expand its product offerings and distribution channels in global markets where medical cannabis is regulated. The company is headquartered in Herzliya, Israel, and its shares are listed on the NASDAQ.
Latest articles
)
The Rise and Fall of Wirecard
A look inside the Wirecard scandal, which took the company from the prestigious DAX 30 to insolvency through the largest accounting fraud in European history.
16 May 2025
)
Lowe's Companies: Building a One-Stop Shop for Home Improvement
Lowe's Companies began as a single store in 1921 and has steadily expanded its footprint and offerings, now operating 1,750 stores across the U.S.
7 May 2025
)
Greg Abel: Succeeding Warren Buffett at Berkshire Hathaway
After decades working with Warren Buffett and Charlie Munger, Greg Abel was named Buffett’s successor as he steps down in late 2025.
5 May 2025
Ticker symbol
INCR
Country
🇺🇸 United States